Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed attachment file name title question first answered answering member label
tabling member	label

Search

422666

	registered interest
	date	20/10/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Haematological Cancer
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, if he will take further steps to support Anthony Nolan's Destination Cure campaign.
	tabling member constituency	York Outer
	tabling member printed	Julian Sturdy
	uin	12658
	answer	answer is ministerial correction date of answer 28/10/2015 answer text <br /> <br /><p>Since 2011, the Department of Health has provided our delivery partners, NHS Blood and Transplant and Anthony Nolan, a total of £16 million in additional, new funding to improve stem cell transplantation services in the United Kingdom. A further £3 million investment was announced in March 2015.</p><br /><p>The Government remains committed to improving stem cell transplantation services and doing all we can to help those in need of a transplant to find a suitable donor. The report ‘Destination Cure – arriving at a better future’ from Anthony Nolan provides a timely contribution to this work.</p><br /> answering member constituency Battersea answering member printed Jane Ellison question first answered 28/10/2015 17:09:26 answering member 3918 label Biography information for Jane Ellison
	tabling member	4079 label Biography information for Julian Sturdy

353921

	registered interest
	date	12/06/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Haematological Cancer
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, if he will make an assessment of the implications for his policies of the recommendations in the report, Destination: Cure - arriving at a better future for people with blood cancer by Anthony Nolan; and if he will make a statement.
	tabling member constituency	North Tyneside
	tabling member printed	Mary Glindon
	uin	2327
	answer	answer is ministerial correction date of answer 22/06/2015 answer text <p>Since 2011, the Department has provided our delivery partners, NHS Blood and Transplant and Anthony Nolan, a total of £16 million in additional, new funding to improve stem cell transplantation services in the United Kingdom. A further £3 million investment was announced in March 2015.</p><p> </p><p> </p><p> </p><p>This funding has led to a tangible improvement in the availability of stem cells in the UK and the achievements include:</p><p> </p><p> </p><p> </p><p>- More UK patients received a stem cell transplant in 2014 than ever before.</p><p> </p><p>- Over 60% of black, Asian and minority ethnic (BAME) patients are now able to find a well matched donor compared to only 40% in 2010.</p><p> </p><p>- A single unified bone marrow donor registry has been created streamlining the provision of stem cells and reducing the time to provide cells from adult donors.</p><p> </p><p>- The proportion of patients receiving cord blood from UK donors has significantly increased.</p><p> </p><p>- The increased use of UK-sourced stem cells has meant that more donors than ever are available to donate leading to a significant cost saving by reducing the need to import stem cells.</p><p> </p><p> </p><p> </p><p>The report ‘Destination Cure – arriving at a better future’ from Anthony Nolan is a timely contribution to the debate on the future of this work.</p><p> </p><p><strong> </strong></p><p> </p><p><strong> </strong></p><p> </p><p><strong> </strong></p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 22/06/2015 16:15:58 answering member 3918 label Biography information for Jane Ellison
	tabling member	4126 label Biography information for Mary Glindon

419210

	registered interest
	date	16/09/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Haematological Cancer
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty’s Government what the Department of Health is doing to prioritise the availability of treatments for rare blood cancers, such as multiple myeloma.
	tabling member printed	Lord Willis of Knaresborough
	uin	HL2283
	answer	answer is ministerial correction date of answer 22/09/2015 answer text <p>Ensuring that the National Health Service is able to support the availability and use of effective medicines for cancers, including rare blood cancer, is a key priority.</p><p> </p><p> </p><p> </p><p>Cancer 52, an organisation which specifically represents patients with rarer cancers, was represented on the independent Cancer Taskforce. The Taskforce published its report, <em>Achieving World-Class Cancer Outcomes: A Strategy for England 2015-2020</em>, in July, and made many recommendations relevant to rarer and blood cancers, focussing in particular on improving access to diagnostic testing, including fast, direct general practitioner access to key blood tests, and increasing patient access to the most advanced treatments. NHS England, Public Health England and other healthcare organisations are now considering the detail of the individual recommendations.</p><p> </p><p> </p><p> </p><p>Earlier in 2015, NHS England consulted on the principles and process by which it makes investment decisions in specialised services, which address the issue of rarity. The outcome of future investment decisions taken by NHS England will be published in accordance with the new process. NHS England’s response to the consultation is attached, and can be found at:</p><p> </p><p> </p><p> </p><p><a href="https://www.england.nhs.uk/commissioning/spec-services/key-docs/" target="_blank">https://www.england.nhs.uk/commissioning/spec-services/key-docs/</a></p><p> </p><p> </p><p> </p><p> </p><p> </p><p>In addition to drug treatments for blood cancers, NHS England also commissions blood and bone marrow transplantation in accordance with its current published policy. A revision of the policy is planned during 2015-16 to be implemented during 2016-17. The current published policy is attached, and can be found at:</p><p> </p><p> </p><p> </p><p><a href="http://www.england.nhs.uk/wp-content/uploads/2013/04/b04-p-a.pdf" target="_blank">http://www.england.nhs.uk/wp-content/uploads/2013/04/b04-p-a.pdf</a></p><p> </p><p> </p><p> </p><p>The National Institute for Health and Care Excellence is developing guidelines for the treatment of multiple myeloma and these are currently subject to public consultation.</p><p> </p> answering member printed Lord Prior of Brampton attachment 1 file name nhse-respns-publictn-17-06-15.pdf title NHS England consultation response 2 file name b04-p-a (1).pdf title Transplantation policy April 2013 question first answered 22/09/2015 10:22:16 answering member 127 label Biography information for Lord Prior of Brampton
	tabling member	4151 label Biography information for Lord Willis of Knaresborough

390634

	registered interest
	date	16/07/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Haematological Cancer
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty’s Government what assessment they have made of the report <i>Destination Cure</i>; and whether they plan to support the calls for a stem cell donor for every person who needs one, a successful transplant for every blood cancer patient, and the right post-transplant care for every patient who needs it.
	tabling member printed	Lord Stevenson of Balmacara
	uin	HL1574
	answer	answer is ministerial correction date of answer 28/07/2015 answer text <p>The Government remains committed to improving stem cell transplantation services and doing all we can to help those in need of a transplant to find a suitable donor.</p><p> </p><p> </p><p> </p><p>Since 2011, the Department has provided our delivery partners, NHS Blood and Transplant and the Anthony Nolan (formerly the Anthony Nolan Trust), a total of £16 million in additional new funding to improve stem cell transplantation services in the United Kingdom. A further £3 million investment was announced in March 2015.</p><p> </p><p> </p><p> </p><p>This funding has led to a tangible improvement in the availability of stem cells in the UK and the achievements include:</p><p> </p><ol start="1" type="1"><li>More UK patients received a stem cell transplant in 2014 than ever before;</li><li>Over 60% of black, Asian and minority ethnic (BAME) patients are now able to find a well matched donor compared to only 40% in 2010;</li><li>A single unified bone marrow donor registry has been created streamlining the provision of stem cells and reducing the time to provide cells from adult donors;</li><li>The proportion of patients receiving cord blood from UK donors has significantly increased; and</li></ol><p> </p><p>5. An increase in UK patients receiving a transplant from 802 in 2010/11 to 1060 in 2013/14. The increased use of UK-sourced stem cells has meant that more donors than ever are available to donate leading to a significant cost saving by reducing the need to import stem cells.</p><p> </p><p> </p><p> </p><p>The report ‘Destination Cure – arriving at a better future’ from Anthony Nolan is a timely contribution to the debate on the future of this work.</p><p> </p> answering member printed Lord Prior of Brampton question first answered 28/07/2015 10:13:47 answering member 127 label Biography information for Lord Prior of Brampton
	tabling member	4175 label Biography information for Lord Stevenson of Balmacara